138661-20-8
Chemical Structure
L-693989
- CAS No.: 138661-20-8
- Formula:C50H80N8NaO20P
- Molecular Weight:1167.18
IUPAC Name: sodium 4-((1S,2S)-2-((2R,9S,11R,12R,14aS,15S,20S,25aS)-20-((R)-3-amino-1-hydroxy-3-oxopropyl)-9-((10R,12S)-10,12-dimethyltetradecanamido)-2,11,12,15-tetrahydroxy-6-((R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-23-yl)-1,2-dihydroxyethyl)phenyl hydrogen phosphate
InChIKey: VAHIZUPRWJROTF-LGKAQAJDSA-M
SMILES: O=C1N2[C@@](C(N[C@@H]([C@@H](C[C@@H](C(NC([C@H](O)C)C(N3[C@](C[C@@H](O)C3)([H])C(NC([C@H](O)[C@H](C4=CC=C(OP(O)(O[Na])=O)C=C4)O)C(N[C@@]1([H])[C@H](O)CC(N)=O)=O)=O)=O)=O)NC(CCCCCCCC[C@@H](C)C[C@@H](C)CC)=O)O)O)=O)([H])[C@@H](O)CC2
Biological Activity: L-693989 is an orally active water-soluble lipopeptide with anticandidal and antipneumocystis activity. L-693989 is effective in preventing the development of both P. carinii cysts. L-693989 is promising for research of P. carinii pneumonia[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-693989 | L-693989 is an orally active water-soluble lipopeptide with anticandidal and antipneumocystis activity. L-693989 is effective in preventing the development of both P. carinii cysts. L-693989 is promising for research of P. carinii pneumonia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
